SaNOtize’s “revolutionary” Covid-19 nasal spray bolstered by Phase II trial data
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19…
Accelerating Clinical Trials
In association with Accelerating Clinical Trials
Trials of Covid-19 long-hauler therapies could repurpose endpoints from other disease studies but evolving definitions pose challenges, experts say
Covid-19 long-hauler treatment trials will likely rely on established endpoints and trial design features used in other conditions, and will…
Latest News
View More
Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of all ongoing and planned hepatology…
Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic
The leading Asia-Pacific biotech specialist CRO Novotech is releasing a series of webinars about the advantages of conducting clinical trials in the Asia-Pacific. Sites across…
Biotechs testing for COVID-19 in Asia-Pacific benefit from new fast-track review processes
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment…
Data shows majority of Australian sites are open for clinical trial activity
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the…
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations hit with the Covid-19 viral…
Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
